On May 21st, the Immunogenicity Discussion Group (IDG) hosted Daniel Kramer from Sanofi, who led the discussion on work that was recently presented at the EIP Symposium – A Retrospective Analysis Comparing Signal-to-Noise with Titer Results (Link to EIP Presentation).
For those unable to attend the session, it is now available on-demand HERE.
Thanks,
Rob & Todd
------------------------------
Robert Nelson
Scientific Officer, Senior Director
BioAgilytix Europe GmbH
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer or other entities to which I am affiliated.
------------------------------